2018 American Transplant Congress
HLA Desensitization Using Rituximab/ Immunoadsorption before Kidney Transplantation
Nephrology, Hemodialyis, Apheresis and Transplantation, CHU Grenoble-Alpes, Grenoble, France.
Introduction: Many kidney-transplant (KT) candidates are sensitized against HLA-antigens, making it difficult to find a suitable HLA-compatible donor. Pretransplant HLA-desensitization strategies have shown improved patient…2018 American Transplant Congress
Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia
Purpose: Ganciclovir-resistant cytomegalovirus (GR-CMV) is serious complication after transplantation. Recurrence after primary GR-CMV infection is common, with literature defined rates of approximately 20-30%. It is…2018 American Transplant Congress
Single-Center Experience with Sofosbuvir-Based HCV Treatment after Kidney Transplantation
Nephrology and Kidney Transplant Department, ISCMPA, Porto Alegre, Brazil.
Chronic hepatitis C (HCV) infection is an important clinical challenge after kidney transplantation. This is the initial report of a single-center experience with sofosbuvir-based HCV…2018 American Transplant Congress
The Implications of Impaired Glucose Tolerance after Kidney Transplantation
Background: Post-transplantation diabetes mellitus (PTDM) is highly prevalent after kidney transplantation and associated with significant morbidity. Routine utilization of screening oral glucose tolerance tests (OGTT)…2018 American Transplant Congress
High Prevalence of New Onset Diabetes Mellitus in a Predominantly Minority Urban Cohort of Kidney Transplant Recipients and Clinical Outcomes
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx.
Background: We aimed to determine the prevalence of new onset diabetes after transplant (NODAT) and its association with clinical outcomes in a cohort of predominantly…2018 American Transplant Congress
Sufficient Hepatic Artery Flow Redeems Poor Portal Vein Flow after Liver Transplantation in Patients with Porta Vein Thrombosis
General Surgery, Cleveland Clinic, Cleveland, OH.
Objective:Although portal vein thrombosis(PVT) in liver transplantation is no longer a contraindication, it remains technically challenging. Insufficient intraoperative PV flow after PV thrombectomy/reconstruction was reported…2018 American Transplant Congress
Platelet Counts as Predictors of Short- and Long-Term Outcomes in Liver Transplantation: Cassandras or Just Rats on a Sinking Ship?
BackgroundThrombocytopenia is associated with higher morbidity and mortality following partial hepatectomy and orthotopic liver transplantation (OLT). Here we investigated platelet counts (PC) as a predictor…2018 American Transplant Congress
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database
Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of extended criteria donors (ECDs), including donation after cardiac death (DCD) donors. The narrow…2018 American Transplant Congress
Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation
Introduction: Liver transplantation (LT) from donors after circulatory death (DCD) is associated with an increased risk of non-anastomotic biliary strictures (NAS) and early graft loss…2018 American Transplant Congress
Most Pediatric Transplant Centers Are Underperforming and in Proximity to Higher Volume Centers
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
Purpose. Many research studies have shown that low case volume has been associated with worse survival outcomes in each type of pediatric solid organ transplant.…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 211
- Next Page »